Related Experiment Videos
Antiestrogens are pro-apoptotic in normal human breast epithelial cells
Sonia Somaï1, Marc Chaouat, Denis Jacob
1INSERM U339, Hôpital Saint-Antoine, Paris, France.
International Journal of Cancer
|May 13, 2003
Summary
Estrogen promotes breast cell growth, while antiestrogens inhibit it. This study shows pure antiestrogen ICI 182780 effectively induces apoptosis in normal breast cells, offering new breast cancer prevention insights.
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- Estrogens stimulate mammary epithelial cell proliferation via cell cycle gene regulation.
- Antiestrogens are crucial for inhibiting estrogen-driven cell growth.
- Understanding hormonal regulation of apoptosis is key for breast cancer treatment.
Purpose of the Study:
- To investigate the hormonal regulation of apoptotic proteins (Bcl-2, p53, caspase-3) in normal human breast epithelial (HBE) cells.
- To compare the effects of estradiol (E2) and antiestrogens (ICI 182780, 4-hydroxytamoxifen) on these proteins.
- To explore the therapeutic potential of antiestrogens in breast cancer prevention.
Main Methods:
- Primary cultures of normal human epithelial breast (HBE) cells were treated with estradiol (E2) and antiestrogens.
- MCF-7 breast adenocarcinoma cells were used for comparative Bcl-2 regulation studies.
- mRNA and protein levels of Bcl-2, p53, and caspase-3 were analyzed.
Main Results:
- Estradiol (E2) increased Bcl-2 mRNA in HBE and MCF-7 cells; ICI 182780 counteracted this in HBE cells and downregulated Bcl-2 in MCF-7 cells.
- In HBE cells, E2 decreased p53 and caspase-3, while ICI 182780 alone increased them.
- ICI 182780 demonstrated potent pro-apoptotic effects in HBE cells, independent of E2, unlike 4-hydroxytamoxifen.
Conclusions:
- ICI 182780 reverses the anti-apoptotic effects of E2 in normal human breast cells.
- ICI 182780 acts as a potent pro-apoptotic agent in HBE cells.
- These findings offer novel therapeutic strategies for breast cancer prevention.